XML 67 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Related Party Transaction [Line Items]          
Accounts receivable $ 11,402,000   $ 11,402,000   $ 10,159,000
Roche related-party deferred revenue 8,190,000   8,190,000   3,742,000
Roche Credit Facility [Member]          
Related Party Transaction [Line Items]          
Credit facility, borrowings outstanding 110,000,000   110,000,000    
Roche [Member]          
Related Party Transaction [Line Items]          
Recognized revenue 14,572,000 $ 9,012,000 30,854,000 $ 18,659,000  
Accounts receivable 11,402,000   11,402,000   10,159,000
Roche related-party deferred revenue 8,190,000   8,190,000   $ 3,742,000
Amount of related party transaction during the period 0 0 0 0  
Roche [Member] | Molecular Information Services [Member]          
Related Party Transaction [Line Items]          
Recognized revenue 12,005,000 5,520,000 26,820,000 11,024,000  
Roche [Member] | Pharma Research and Development Services [Member]          
Related Party Transaction [Line Items]          
Recognized revenue 2,567,000 3,492,000 4,034,000 7,635,000  
Roche [Member] | Molecular Information Platform Program and x-U.S. Commercialization Agreement [Member] | Molecular Information Services [Member]          
Related Party Transaction [Line Items]          
Recognized revenue 12,005,000 5,520,000 26,820,000 11,024,000  
Cost of related-party molecular information services from Roche 4,800,000 2,045,000 10,748,000 2,945,000  
Roche [Member] | CDx Development, Immunotherapy Testing Platform Development and Other Programs [Member] | Pharma Research and Development Services [Member]          
Related Party Transaction [Line Items]          
Recognized revenue $ 2,567,000 $ 3,492,000 $ 4,034,000 $ 7,635,000